A study has shown that H19 exacerbates liver fibrosis by interacting with miR-148a to induce overexpression of USP4, leading to activation of HSCs by inhibiting degradation of Smad4 or TGF-βRI and enhancing TGF-β signaling [39]. Here, USP4 is linked to Hepatic fibrosis.